BofA reiterates Neutral on Nike stock, keeps $55 price target

Nike is facing cautious analyst sentiment after BofA reaffirmed a Neutral rating with a $55 price target, while UBS cut its target to $50 and RBC downgraded the stock to Sector Perform. The company is expected to post Q4 EPS of $0.11 on sales down 3%, with fiscal 2027 guidance unlikely and management focus shifting to North America sell-through and China. Nike also announced CFO transition changes and said Q4 results will include a one-time tariff refund benefit.

Analysis

Nike is becoming a classic “good business, bad tape” setup where the market is pricing in not just a soft quarter, but a prolonged reset in earnings power. The key second-order issue is that the brand’s North America stabilization is being offset by inventory digestion and promotional intensity elsewhere, which can keep gross margin recovery slower than the street wants even if unit demand improves. In that scenario, the stock can remain range-bound near lows because multiple expansion usually requires evidence that sell-through is translating into cleaner channel inventory, not just better commentary.

The CFO change matters less for optics than for capital allocation credibility: a new finance lead often tightens the guidance framework, which can initially reduce perceived flexibility but eventually help reset expectations more cleanly. If management uses the upcoming investor day to frame a multi-year margin bridge, the near-term reaction could be positive, but if the event slips or is light on detail, the market will read that as confirmation that earnings visibility is still poor. The tariff refund benefit is a non-recurring patch, so removing it from the debate leaves investors focused on core demand and mix, which are still the real drivers of the multiple.

Competitively, weakness at Nike tends to be a relative tailwind for premium athletic peers with cleaner growth vectors, but it also creates a broader promotion backdrop that can pressure the entire footwear/apparel channel. The most interesting trade is not to bet on a sharp absolute rebound in NKE, but on timing: the stock could bounce if the company avoids a guidance shock, yet the risk/reward remains asymmetric to the downside if first-quarter sell-through or China commentary disappoints. Over the next 1-3 months, the catalyst stack is dense enough that implied volatility should stay elevated; over 6-12 months, the question is whether margin repair is real or just inventory math.

Key Decisions for Investors

• Stay underweight NKE into the next earnings print; the setup favors a downside surprise on forward guide versus a modest beat on the reported quarter, with limited upside until management proves sell-through durability.
• Use a bearish options expression in NKE: buy 1-2 month puts or put spreads struck near the recent lows to capture the risk of a post-print reset in FY27/FY28 expectations; risk/reward improves if implied vol stays below the event-normal level.
• Pair trade: long a cleaner-growth athletic peer basket vs short NKE into investor-day/earnings season; the relative trade benefits if Nike’s recovery narrative remains too slow for the market while competitors with less China exposure hold up better.
• If NKE rallies on a non-disastrous guide, fade the move rather than chase it; the better entry for a long would be after a confirmed sell-through inflection or a more explicit margin bridge, not on headline relief.
• Watch for a tactical short-covering window only if management definitively commits to a detailed long-term roadmap; absent that, treat any bounce as a trade, not a thesis change.